论文部分内容阅读
目的:评价小儿慢性原发免疫性血小板减少症中医诊疗指南临床应用效果。方法:按照国家中医药管理局中医诊疗指南临床应用评价实施方案的要求,由11家医疗机构采用回顾性病例观察的方法,主要围绕指南内容的临床适用性、可操作性进行评估,从诊断、辨证、治疗等方面与指南内容进行比较,填写一致性测试表及一致性测试报告。结果:226例临床资料与指南比较,诊断部分、预防与调摄部分一致性较高,辨证分型及治则一致性稍低,由于患儿兼加症及地区用药不同,药物组成、中成药及其它治法一致性较低。结论:小儿慢性原发免疫性血小板减少症诊疗指南基本符合临床实践,可作为临床医生治疗本病的标准中医指南。
Objective: To evaluate the clinical application of TCM diagnosis and treatment guideline for chronic primary immune thrombocytopenia in children. Methods: In accordance with the requirements of the clinical application evaluation plan of the State Administration of TCM for TCM, 11 medical institutions adopted the method of retrospective case observation, which mainly focused on the clinical applicability and maneuverability of the guideline contents. From the diagnosis, Dialectical, treatment and other aspects of the guide to compare, fill in the conformance test form and conformance test report. Results: 226 cases of clinical data and guidelines, diagnosis, prevention and transfer of part of the higher consistency, syndrome differentiation and consistency of the treatment is slightly lower, due to children with additional disease and regional drug use, drug composition, proprietary Chinese medicines and Other laws are less consistent. Conclusion: The guidelines for the diagnosis and treatment of chronic primary immune thrombocytopenia in children are in line with clinical practice and can be used as a standard Chinese medicine guideline for clinicians in treating this disease.